Please login to the form below

Not currently logged in
Email:
Password:

Making the most of the NHS Information Revolution


The NHS is a source of rich data, including hospital episode statistics (HES), medicines prescriptions and GP performance measures (QOF), more and more of which is now becoming available in the public domain and at increasing levels of granularity. However, these are held in silos, in different formats, and so making the most of this massive opportunity is a real challenge for the pharmaceutical sector.

As a result of recent government data transparency initiatives, there has never been more of this NHS information publicly available, and even more detailed prescription data will be available later this year. But how can you turn these disparate data sources into valuable information that is quickly and cost-effectively available to help make critical business decisions?

Datapharm, a company with a well-established reputation with both the NHS and the pharmaceutical industry for turning complex data into user-friendly information, is pleased to offer you an invitation to a free webinar to explore how you can make the most of this data revolution. The webinar is produced in association with PMGroup.

Can't see the embedded webinar link below? Join the webinar on BrightTalk.


Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics